orlitroy

Introduction to orlitroy

Orlitroy is a medication primarily used for weight management in individuals with overweight or obesity. It is available in tablet form. Orlitroy helps in weight loss by blocking the absorption of some of the fat you consume. This medicine is used alongside a low-calorie, low-fat diet and an exercise plan.

Composition of orlitroy

Orlitroy contains the active ingredient Orlistat, which works by inhibiting the enzyme lipase. This enzyme is responsible for breaking down fat in your diet. By blocking lipase, Orlitroy prevents the absorption of some dietary fats, which are then eliminated from the body.

Uses of orlitroy

• Weight management in overweight or obese individuals
• Improvement of health markers such as blood pressure and cholesterol levels

Side effects of orlitroy

• Common side effects: oily stools, flatulence, frequent bowel movements
• Serious side effects: allergic reactions, severe abdominal pain, liver problems

Precautions of orlitroy

Orlitroy should not be used if you have chronic malabsorption syndrome or cholestasis. It is also contraindicated if you are allergic to Orlistat or any of its ingredients. Use with caution if you have a history of kidney stones or liver problems.

How to Take orlitroy

The usual dose of Orlitroy for adults is 120 mg taken with each main meal containing fat, up to three times a day. It is important to follow a low-fat diet to minimize gastrointestinal side effects. Orlitroy is not typically recommended for children under 12 years. Always follow your doctor's specific dosage instructions.

Conclusion of orlitroy

Orlitroy is a weight management medication containing Orlistat, belonging to the therapeutic class of lipase inhibitors. It is manufactured for individuals with overweight or obesity to aid in weight loss and improve health markers. Orlitroy should be used in conjunction with a low-calorie, low-fat diet and exercise plan. Always consult your healthcare provider for personalized advice and follow their instructions carefully.